Is GSK or OGN a better buy right now?

Based on our latest analysis, GSK and OGN are evenly matched based on our comprehensive scoring model.

Does GSK or OGN have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: GSK or OGN?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

GSK vs OGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 20, 2026

GSK

58.5

AI Score

It's a Tie!

OGN

58.5

AI Score

Investment Advisor Scores

GSK

59score

Recommendation

HOLD

View Full Analysis

OGN

59score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

Detailed Metrics Comparison

Metric	GSK	OGN	Winner
Valuation Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples.
Forward P/E	21.5054	5.0891	OGN
PEG Ratio	19.3811	0	Tie
Growth Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations.
Revenue Growth	1.5%	-3.5%	GSK
Earnings Growth	8.4%	66.7%	OGN
Quality & Profitability Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages.
Tradestie Score	58.5/100	58.5/100	Tie
Profit Margin	17.8%	4.0%	GSK
Risk Profile Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility.
Beta	1.00	1.00	Tie
Sentiment AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction.
AI Recommendation	HOLD	HOLD	Tie

Frequently Asked Questions

Based on our detailed analysis, GSK and OGN are evenly matched. This is a close call that depends on your specific investment goals.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

GSK

OGN

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Jun 20, 2026 01:40 UTC. Refresh Data

Tradestie